1-9 of 9
Kevin M. Elias
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A045: Improving the diagnostic accuracy of an ovarian cancer triage test using a joint miRNA-protein model

James W. Webber, Laura Wollborn, Sudhanshu Mishra, Allison Vitonis, Daniel W. Cramer, Ryan Phan, Todd Pappas, Dipanjan Chowdhury, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A045.
https://doi.org/10.1158/1538-7445.OVARIAN23-A045
Published: 04 March 2024
View article titled, Abstract A045: Improving the diagnostic accuracy of an ovarian cancer triage test using a joint miRNA-protein model
Journal Articles

Abstract B048: Evaluating the impact of pulmonary diseases on the use of microRNAs as biomarkers for early detection of ovarian cancer

Monica Moore, Laura Wollborn, Sudhanshu Mishra, James Webber, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B048.
https://doi.org/10.1158/1538-7445.OVARIAN23-B048
Published: 04 March 2024
View article titled, Abstract B048: Evaluating the impact of pulmonary diseases on the use of microRNAs as biomarkers for early detection of ovarian cancer
Journal Articles

Abstract A011: An implantable microdevice to interrogate responses to therapy in ovarian cancer

Elizabeth H. Stover, Zuzana Tatarova, Sharath K. Bhagavatula, Christine Dominas, Madeline Polak, Alexis Rabbitt, Jeanette Gardner, Kim MacNeill, Natalie Azzolini, Sebastian Ahn, Michael J. Worley, Jr., Kevin M. Elias, David L. Kolin, Joyce F. Liu, Ursula A. Matulonis, Stuart G. Silverman, Neil S. Horowitz, Oliver Jonas
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A011.
https://doi.org/10.1158/1538-7445.OVARIAN23-A011
Published: 04 March 2024
View article titled, Abstract A011: An implantable microdevice to interrogate responses to therapy in ovarian cancer
Journal Articles

Abstract B044: Serum miRNA expression in ovarian cancer patients is independent of histological subtype and FIGO stage

Laura Wollborn, James W. Webber, Sudhanshu Mishra, Chad B. Sussman, Cameron E. Comrie, Daniel G. Packard, Allison Vitonis, Stephanie Alimena, Ryan Phan, Todd Pappas, Daniel W. Cramer, Dipanjan Chowdhury, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B044.
https://doi.org/10.1158/1538-7445.OVARIAN23-B044
Published: 04 March 2024
View article titled, Abstract B044: Serum miRNA expression in ovarian cancer patients is independent of histological subtype and FIGO stage
Journal Articles

Abstract 1931: Multi-cancer classification: An analysis of neural network complexity

James W. Webber, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1931.
https://doi.org/10.1158/1538-7445.AM2022-1931
Published: 15 June 2022
View article titled, Abstract 1931: Multi-cancer classification: An analysis of neural network complexity
Journal Articles

Abstract 2747: Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

Inga-Maria P. Launonen, Nuppu Lyytikäinen, Julia Casado, Ella A. Anttila, Connor A. Jacobson, Jia R. Lin, Zoltan Maliga, Sandro Santaga, Kevin M. Elias, Alan D. D'Andrea, Panagiotis A. Konstantinopoulos, Peter K. Sorger, Anniina Färkkilä
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2747.
https://doi.org/10.1158/1538-7445.AM2021-2747
Published: 01 July 2021
View article titled, Abstract 2747: Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
Journal Articles

Abstract 1316: PAX8-directed nanotherapeutics for high-grade serous ovarian cancer

Akshaya Chandrasekaran, Mariam Ahmed, Nicole Holub, Wade Wang, Paula T. Hammond, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1316.
https://doi.org/10.1158/1538-7445.AM2021-1316
Published: 01 July 2021
View article titled, Abstract 1316: PAX8-directed nanotherapeutics for high-grade serous ovarian cancer
Journal Articles

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Changxin Wan, Matthew P. Keany, Han Dong, Linah F. Al-Alem, Unnati M. Pandya, Suzan Lazo, Karsten Boehnke, Katherine N. Lynch, Rui Xu, Dominique T. Zarrella, Shengqing Gu, Paloma Cejas, Klothilda Lim, Henry W. Long, Kevin M. Elias, Neil S. Horowitz, Colleen M. Feltmate, Michael G. Muto, Michael J. Worley, Jr, Ross S. Berkowitz, Ursula A. Matulonis, Marisa R. Nucci, Christopher P. Crum, Bo R. Rueda, Myles Brown, Xiaole Shirley Liu, Sarah J. Hill
Journal: Cancer Research
Series: Author Choice
Cancer Res (2021) 81 (1): 158–173.
https://doi.org/10.1158/0008-5472.CAN-20-1674
Published: 04 January 2021
View article titled, Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Open the PDF for Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 6241: PAX8-directed nanotherapeutics for high-grade serous ovarian carcinoma

Akshaya Chandrasekaran, Mariam Ahmed, Wade Wang, Paula T. Hammond, Kevin M. Elias
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6241.
https://doi.org/10.1158/1538-7445.AM2020-6241
Published: 15 August 2020
View article titled, Abstract 6241: PAX8-directed nanotherapeutics for high-grade serous ovarian carcinoma